|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.78 CHF | -6.76% |
|
+2.71% | +24.43% |
| 07-08 | DSM-Firmenich slips despite share buybacks and Jefferies' positive view | |
| 07-01 | What to know about sunscreens in heat waves | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.21 | 2.44 | -1.35 | 0.94 | 1.25 | |||||
Return on Total Capital | 5.43 | 3.09 | -1.67 | 1.14 | 1.52 | |||||
Return On Equity % | 12.9 | 4.69 | -3.75 | 1.22 | 1.66 | |||||
Return on Common Equity | 12.91 | 4.53 | -3.91 | 1.1 | 1.34 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 34.38 | 32.06 | 24.57 | 33.17 | 39.07 | |||||
SG&A Margin | 19.44 | 21.12 | 23.85 | 22.25 | 24.45 | |||||
EBITDA Margin % | 17.58 | 14.71 | 3.31 | 12.49 | 15.92 | |||||
EBITA Margin % | 13.52 | 10.63 | -0.78 | 8.74 | 13 | |||||
EBIT Margin % | 11.11 | 7.77 | -5.27 | 3.98 | 6.96 | |||||
Income From Continuing Operations Margin % | 11.83 | 5.66 | -5.98 | 2.19 | 3.79 | |||||
Net Income Margin % | 18.21 | 20.26 | 20.11 | 1.95 | -11.97 | |||||
Net Avail. For Common Margin % | 11.72 | 5.41 | -6.19 | 1.95 | 3.03 | |||||
Normalized Net Income Margin | 6.26 | 4 | -4.39 | 1.58 | 2.21 | |||||
Levered Free Cash Flow Margin | 13.98 | -7.67 | 1.74 | 4.66 | -0.36 | |||||
Unlevered Free Cash Flow Margin | 14.61 | -6.9 | 2.55 | 5.45 | 0.71 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.61 | 0.5 | 0.41 | 0.38 | 0.29 | |||||
Fixed Assets Turnover | 2.38 | 2.23 | 2.33 | 2.27 | 1.83 | |||||
Receivables Turnover (Average Receivables) | 6.15 | 5.39 | 5.23 | 4.98 | 4.08 | |||||
Inventory Turnover (Average Inventory) | 2.89 | 2.46 | 2.8 | 2.56 | 2.03 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.52 | 3.15 | 1.96 | 2.02 | 1.59 | |||||
Quick Ratio | 1.54 | 1.73 | 1.18 | 1.25 | 0.71 | |||||
Operating Cash Flow to Current Liabilities | 0.59 | 0.37 | 0.28 | 0.41 | 0.26 | |||||
Days Sales Outstanding (Average Receivables) | 59.37 | 67.69 | 69.74 | 73.52 | 89.49 | |||||
Days Outstanding Inventory (Average Inventory) | 126.18 | 148.43 | 130.43 | 142.91 | 179.42 | |||||
Average Days Payable Outstanding | 78.22 | 94.46 | 69.92 | 96.05 | 157.7 | |||||
Cash Conversion Cycle (Average Days) | 107.32 | 121.67 | 130.25 | 120.38 | 111.2 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 32.93 | 28.27 | 20.95 | 23.26 | 28.64 | |||||
Total Debt / Total Capital | 24.77 | 22.04 | 17.32 | 18.87 | 22.27 | |||||
LT Debt/Equity | 31.81 | 27.46 | 17.83 | 19.58 | 19.63 | |||||
Long-Term Debt / Total Capital | 23.93 | 21.41 | 14.74 | 15.88 | 15.26 | |||||
Total Liabilities / Total Assets | 41.32 | 37.68 | 32.68 | 32.74 | 37.22 | |||||
EBIT / Interest Expense | 11.12 | 6.27 | -4.06 | 3.14 | 4.08 | |||||
EBITDA / Interest Expense | 18.14 | 12.35 | 3.09 | 10.46 | 9.92 | |||||
(EBITDA - Capex) / Interest Expense | 13.43 | 7.48 | -0.93 | 6.48 | 5.84 | |||||
Total Debt / EBITDA | 1.85 | 2.39 | 11.32 | 3.12 | 3.45 | |||||
Net Debt / EBITDA | 0.63 | 0.14 | 5.32 | 1.51 | 2.21 | |||||
Total Debt / (EBITDA - Capex) | 2.5 | 3.94 | -37.76 | 5.03 | 5.86 | |||||
Net Debt / (EBITDA - Capex) | 0.84 | 0.24 | -17.73 | 2.44 | 3.75 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 13.55 | 15.42 | 26.66 | 20.44 | -0.22 | |||||
Gross Profit, 1 Yr. Growth % | 13.98 | 2.99 | -2.94 | 62.58 | -0.65 | |||||
EBITDA, 1 Yr. Growth % | 33.83 | -5.44 | -71.47 | 363.48 | 4.51 | |||||
EBITA, 1 Yr. Growth % | 43.82 | -4.19 | -109.3 | -1.45K | 8.4 | |||||
EBIT, 1 Yr. Growth % | 52.23 | -8.17 | -185.89 | -190.89 | 19.35 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 138.29 | -42.77 | -233.89 | -144.03 | -4.74 | |||||
Net Income, 1 Yr. Growth % | 231.23 | 1.43 | 25.71 | -88.3 | -532.4 | |||||
Normalized Net Income, 1 Yr. Growth % | 75.94 | -12.48 | -239.03 | -143.4 | -6.51 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 139.82 | -44.69 | -207.91 | -133.31 | -7.36 | |||||
Accounts Receivable, 1 Yr. Growth % | 15.24 | -5.99 | 69.3 | 1.41 | -28.89 | |||||
Inventory, 1 Yr. Growth % | 22.25 | 1.83 | 44.93 | -2.95 | -35.53 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.82 | -9.79 | 55.17 | 3.17 | -27.09 | |||||
Total Assets, 1 Yr. Growth % | 11.62 | 8.63 | 96.92 | -1.53 | -13.04 | |||||
Tangible Book Value, 1 Yr. Growth % | 35.45 | 39.59 | -25.48 | 6.31 | -35.48 | |||||
Common Equity, 1 Yr. Growth % | 25.94 | 15.29 | 113.24 | -1.73 | -18.96 | |||||
Cash From Operations, 1 Yr. Growth % | -4.48 | -32.38 | 31.09 | 40.55 | -18.73 | |||||
Capital Expenditures, 1 Yr. Growth % | -5.46 | 16.86 | 9.68 | 16.22 | -2.64 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -622.59 | -159.02 | -127.76 | 235.79 | -109.12 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -807.57 | -150.4 | -145.13 | 164.44 | -85.76 | |||||
Dividend Per Share, 1 Yr. Growth % | 4.17 | 1.2 | -1.19 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 7.27 | 1.74 | 20.91 | 23.51 | -7.8 | |||||
Gross Profit, 2 Yr. CAGR % | 6.99 | -1.56 | -0.02 | 25.62 | 16.27 | |||||
EBITDA, 2 Yr. CAGR % | 12.21 | 1.03 | -48.06 | 13.83 | 104.16 | |||||
EBITA, 2 Yr. CAGR % | 13.01 | 1.55 | -70.14 | 11.95 | 276.09 | |||||
EBIT, 2 Yr. CAGR % | 12.59 | -1.5 | -11.19 | -11.64 | 5.98 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 25.72 | 1.95 | -12.46 | -23.22 | -26.67 | |||||
Net Income, 2 Yr. CAGR % | 48.7 | 83.29 | 12.92 | -61.65 | -28.88 | |||||
Normalized Net Income, 2 Yr. CAGR % | 15.2 | 1.25 | 10.31 | -22.32 | -34.65 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 27.69 | 0.4 | -22.75 | -40.04 | -38.89 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.34 | 4.12 | 26.16 | 31.03 | -15.08 | |||||
Inventory, 2 Yr. CAGR % | 6.66 | 11.57 | 21.48 | 18.6 | -20.9 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -1.03 | -2.67 | 18.32 | 26.53 | -13.27 | |||||
Total Assets, 2 Yr. CAGR % | 9.14 | 10.14 | 46.26 | 39.25 | -7.46 | |||||
Tangible Book Value, 2 Yr. CAGR % | -2.5 | 37.52 | 1.99 | -11 | -17.18 | |||||
Common Equity, 2 Yr. CAGR % | 9.79 | 20.5 | 56.8 | 44.76 | -10.76 | |||||
Cash From Operations, 2 Yr. CAGR % | 1.5 | -19.63 | -5.85 | 35.74 | 6.88 | |||||
Capital Expenditures, 2 Yr. CAGR % | -8.75 | 5.11 | 13.21 | 12.9 | 6.37 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 181.52 | 61.65 | -58.84 | -5.3 | -57.49 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 145.88 | 74.49 | -51.41 | 7.82 | -50.72 | |||||
Dividend Per Share, 2 Yr. CAGR % | 2.06 | 2.67 | 0 | -0.59 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.23 | 1.61 | 9.45 | 20.75 | 2.5 | |||||
Gross Profit, 3 Yr. CAGR % | -2.42 | -0.9 | -2.02 | 17.57 | 9.48 | |||||
EBITDA, 3 Yr. CAGR % | -0.99 | -1.34 | -33.72 | 7.01 | 5.23 | |||||
EBITA, 3 Yr. CAGR % | -2.62 | -2.89 | -54.22 | 6.29 | 9.59 | |||||
EBIT, 3 Yr. CAGR % | -5.42 | -6.86 | -5.9 | -10.5 | -1.19 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 0.31 | -11.66 | 11.65 | -30.39 | -10.37 | |||||
Net Income, 3 Yr. CAGR % | 15.88 | 30.9 | 61.64 | -46.97 | -14.01 | |||||
Normalized Net Income, 3 Yr. CAGR % | -6.15 | -8.21 | 12.54 | -19.17 | -15.95 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 0.88 | -11.84 | 2.84 | -41.64 | -26.13 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.59 | -1.79 | 22.44 | 17.3 | 6.88 | |||||
Inventory, 3 Yr. CAGR % | 4.85 | 5.03 | 21.74 | 12.72 | -3.21 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.07 | -3.99 | 13.7 | 13.04 | 5.29 | |||||
Total Assets, 3 Yr. CAGR % | 5.49 | 8.99 | 33.68 | 28.19 | 19.02 | |||||
Tangible Book Value, 3 Yr. CAGR % | -5.12 | 9.9 | 12.12 | 3.41 | -20.05 | |||||
Common Equity, 3 Yr. CAGR % | 6.19 | 11.59 | 45.75 | 34.18 | 19.31 | |||||
Cash From Operations, 3 Yr. CAGR % | 0.86 | -11.35 | -5.4 | 7.61 | 14.41 | |||||
Capital Expenditures, 3 Yr. CAGR % | -8.49 | -0.91 | 6.61 | 14.21 | 7.47 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 50.57 | 58.25 | -9.13 | -18.19 | -63.59 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 45.37 | 37.53 | 12.57 | -15.27 | -52.56 | |||||
Dividend Per Share, 3 Yr. CAGR % | 2.82 | 1.77 | 1.37 | 0 | -0.4 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.05 | -0.57 | 2.78 | 9.86 | 2.19 | |||||
Gross Profit, 5 Yr. CAGR % | 3.55 | -1.71 | -5.17 | 8.96 | 4.92 | |||||
EBITDA, 5 Yr. CAGR % | 8.42 | -0.32 | -26.73 | 4.47 | 3.53 | |||||
EBITA, 5 Yr. CAGR % | 10.27 | -0.96 | -42.73 | 2.8 | 6.3 | |||||
EBIT, 5 Yr. CAGR % | 10.36 | -3.94 | -14.27 | -8.81 | -1.31 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 10.64 | -23.23 | -10.03 | -16.48 | -5.63 | |||||
Net Income, 5 Yr. CAGR % | 21.97 | -0.79 | 14.69 | -19.9 | 16.4 | |||||
Normalized Net Income, 5 Yr. CAGR % | 15.41 | -1.89 | -7.7 | -14.14 | -9.45 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 11.13 | -23.59 | -14.18 | -24.44 | -16.49 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.28 | -0.44 | 10.14 | 10.21 | 5.77 | |||||
Inventory, 5 Yr. CAGR % | 5 | 4.83 | 11.21 | 10.26 | 2.45 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 3.54 | 1.54 | 9.59 | 7.22 | 2.03 | |||||
Total Assets, 5 Yr. CAGR % | 4.32 | 6.33 | 20.23 | 20.21 | 15.39 | |||||
Tangible Book Value, 5 Yr. CAGR % | 6.8 | 7.47 | -2.33 | 1.01 | -0.68 | |||||
Common Equity, 5 Yr. CAGR % | 8.94 | 9.06 | 24.1 | 23.83 | 19.78 | |||||
Cash From Operations, 5 Yr. CAGR % | 6.99 | -0.63 | -1.88 | 5.12 | -0.66 | |||||
Capital Expenditures, 5 Yr. CAGR % | 0.95 | 2.42 | -0.36 | 4.4 | 6.52 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 29.9 | 32.62 | -13.29 | 29.74 | -33.46 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 26.1 | 19.93 | -9.14 | 25.71 | -19.53 | |||||
Dividend Per Share, 5 Yr. CAGR % | 7.39 | 6.46 | 1.68 | 0.82 | 0.82 |
- Stock Market
- Stocks
- DSFIR Stock
- Financials DSM-Firmenich
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















